arrow
P

Pengcheng Han

Advanced Institute for Life and Health
H指数:12
被引数:956

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19

基于血管紧张素转换酶2、糖蛋白130和肿瘤坏死因子受体2的三特异性融合蛋白的开发,作为一种有前景的COVID-19治疗方法

2025-10-150
OA